Breaking News
January 22, 2018 - Mallinckrodt Completes Stannsoporfin New Drug Application Filing
January 22, 2018 - ACOG Backs ‘Cascade Testing’ for Cancer-Related Mutations
January 22, 2018 - The terrible toll tennis can take on top players who play too much
January 22, 2018 - KAIST scientists identify cellular mechanism for severe viral hepatitis
January 22, 2018 - New genomic tools provide better understanding of the human immune system
January 22, 2018 - Improving QoL with an App?
January 22, 2018 - First step toward CRISPR cure of Lou Gehrig’s disease
January 22, 2018 - Scientists uncover the proteins responsible for movement
January 22, 2018 - New clinical practice guideline provides recommendations for use of anticoagulants during heart surgery
January 22, 2018 - Depressive symptoms associated with poorer survival in patients with head and neck cancer
January 22, 2018 - Restaurant Bans Have Big Impact on Smoking Rates
January 22, 2018 - D.C. Week: CMS Outlines Path for Medicaid Work Mandate
January 22, 2018 - Study identifies new loci associated with asthma enriched in epigenetic marks
January 22, 2018 - New bug may reduce misery of hay fever sufferers
January 22, 2018 - Specially prepared supplement helps women to run faster, study shows
January 22, 2018 - 3-D Stent Retriever with Aspiration Proves Mettle in AIS
January 22, 2018 - Public health research seeks to understand how natural disasters impact spread of Zika
January 22, 2018 - Research reveals role of nanophenomenon in stimulating bone-repair process
January 22, 2018 - Drinking during late adolescence could be first step to liver problems in adulthood
January 22, 2018 - Epilepsy associated with volume and thickness differences in brain matter
January 22, 2018 - Trevena Announces FDA Acceptance for Review of New Drug Application for Olinvo (oliceridine) Injection
January 22, 2018 - A Noteworthy Margin of Error
January 22, 2018 - Firm advances human trials of revolutionary vaccine
January 22, 2018 - Many Indians put away treating orthopedic problems
January 22, 2018 - Cherwell releases new pocket guide to prepared culture media
January 22, 2018 - Huron earns ISO 13485 certification for quality management system
January 22, 2018 - Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
January 22, 2018 - Multi-Gene Test For Early CVD; Neighborhood HF Risk; Novel Testosterone Drugs
January 22, 2018 - Skipping breakfast disrupts ‘clock genes’ that regulate body weight
January 22, 2018 - Creativity May Rely on ‘Teamwork’ in the Brain
January 22, 2018 - NeuroBreak: Alzheimer’s Germ Contest; High Salt Diet May Be Bad for Brain
January 22, 2018 - Diabetics may often fare poorly in hospice care
January 22, 2018 - Performance enhancing benefits of caffeine more apparent for infrequent tea, coffee drinkers
January 22, 2018 - HHS Unveils Framework for Interoperability
January 22, 2018 - More dentists to discuss risks of HPV-related cancers with their patients
January 21, 2018 - Research shows how Zika virus damages placenta to cause malformations in babies
January 21, 2018 - Achaogen Announces FDA Acceptance of New Drug Application with Priority Review for Plazomicin for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
January 21, 2018 - Drug Allergies: Time to Re-Test?
January 21, 2018 - Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds
January 21, 2018 - Women more likely than men to die from a heart attack
January 21, 2018 - Next generation genomic sequencing can help detect pathogens after joint replacement
January 21, 2018 - Gov’t Shutdown Looms as Senate Debates Spending Bill
January 21, 2018 - Emergency Readiness for Older Adults and People with Disabilities
January 21, 2018 - Heart health at risk for Latinas over worries about deportation
January 21, 2018 - Scientists methodically identify genes related to blood feeding and non-biting mosquitoes
January 21, 2018 - Researchers discover potential target genes to halt thyroid cancer progression
January 21, 2018 - Youth with shared residency after parents’ divorce have less mental issues
January 21, 2018 - Sleep Better, Lose Weight? – Drugs.com MedNews
January 21, 2018 - More $$ Needed for Health Emergencies, Senators Told
January 21, 2018 - Gene test to predict breast cancer recurrence less cost effective in real world practice
January 21, 2018 - Study finds rise in number of adolescents receiving psychiatric or neurodevelopmental diagnosis
January 21, 2018 - Reminders can improve immunization rates
January 21, 2018 - A More Personalized Approach to PSA Screening in 2017
January 21, 2018 - T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma
January 21, 2018 - Tetraphase Pharmaceuticals Announces Submission of New Drug Application to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
January 21, 2018 - Have Robotics Had a Detrimental Effect on Surgical Residency?
January 21, 2018 - Being bilingual may help autistic children
January 21, 2018 - Metrics Are Not Widespread in Rheumatoid Care
January 21, 2018 - Neuroanatomic abnormalities ID’d in those at risk for autism
January 21, 2018 - Children born with Down’s syndrome have superior genome that compensates for disability
January 21, 2018 - Study finds higher risks for asymptomatic paroxysmal AF patients
January 21, 2018 - The Second Stage of Diet Resolutions
January 21, 2018 - CT Scans Reduce Lung Cancer Deaths … But Among Whom?
January 21, 2018 - ADHD drug use soars among young women
January 21, 2018 - Researchers propose new regulation mechanism linked to action of SirT6 on chromatin
January 21, 2018 - Statins appear to reduce risk of repeated surgery in patients who undergo vitrectomy
January 21, 2018 - Morning Break: Hep A Outbreak Spreads; Tide Pod Challenge; Keeping Lobsters Out of Hot Water
January 21, 2018 - EULAR and ACR present SLE classification criteria at the 2017 ACR/ARHP Annual Meeting
January 21, 2018 - Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for Azedra (iobenguane I 131) in Pheochromocytoma and Paraganglioma
January 21, 2018 - House Passes Funding Bill with 6-Year CHIP Renewal
January 21, 2018 - DASH ranked Best Diet Overall for eighth year in a row by U.S. News and World Report
January 21, 2018 - Dementia study sheds light on how damage spreads through brain
January 20, 2018 - Morning Break: Missing Maria Deaths; N.J. Doc Charged in Wife’s Murder; Viva Vaseline!
January 20, 2018 - No interventions proven to prevent late-life dementia
January 20, 2018 - Judge orders new Olympus trial over superbug death
January 20, 2018 - Don’t Rely on Just One Blood Pressure Test for Kids: Study
January 20, 2018 - Going Off the Deep End About Water
January 20, 2018 - Parental attention can reduce risk of drug abuse in adolescence
January 20, 2018 - Mast Uri System offers efficient and cost-friendly diagnostic solution
January 20, 2018 - International SOS, Chatham House sign partnership agreement to further advance Global Health Security Agenda
Pregnancy-Linked VTE Risk Varies by Type of Thrombophilia

Pregnancy-Linked VTE Risk Varies by Type of Thrombophilia

image_pdfDownload PDFimage_print

Absolute risk of pregnancy-associated venous thromboembolism (VTE) varied depending on the type of thrombophilia among women with a family history of VTE, a systematic review and meta-analysis found.

While all thrombophilias increased the risk of pregnancy-associated VTE, those with the highest absolute risk were antithrombin deficiency, protein C deficiency, protein S deficiency and homozygous factor V Leiden, reported F. Nanne Croles, MD, of Erasmus University Medical Centre in the Netherlands, and colleagues.

But absolute risks of pregnancy-associated VTE were much lower for women with heterozygous factor V Leiden, heterozygous prothrombin G20210A mutations, or compound heterozygous factor V Leiden and prothrombin G20210A mutations, the authors wrote in The BMJ.

They noted that the 2012 American College of Chest Physicians (ACCP) guidelines about absolute risk estimates of pregnancy-associated VTE in women with inherited thrombophilia “are based on a limited number of cohort studies” and an estimated baseline incidence of VTE multiplied by odds ratios found in prior research. But they added that “no systematic review or meta-analysis of absolute risk of pregnancy-associated VTE for women with thrombophilia has been published.”

Researchers examined 36 observational studies reporting on pregnancies without the use of anticoagulants, as well as the outcome of first VTE for women with thrombophilia. Venous thromboembolism was defined by the condition being “confirmed by objective means” or if the patient received “a full course of a full dose anticoagulant treatment without objective testing.”

Antithrombin deficiency had the highest absolute risk of both antepartum (7.3%, 95% CI 1.8%-15.6%) and post-partum (11.1%, 95% CI 3.7%-21.0%) pregnancy-associated VTE — albeit with wide confidence intervals. Thrombophilias with the smallest absolute combined risk (heterozygous factor V Leiden, heterozygous prothrombin G20210A mutations, and compound heterozygous factor V Leiden and prothrombin G20210A mutations) were all below 3%, the authors said.

Croles and colleagues noted that, compared against the ACCP guidelines, their meta-analysis found “markedly higher” absolute risk estimates for women with antithrombin and protein C deficiency (antepartum: 3.2%, 95% CI 0.6%-8.2%; postpartum: 5.4%, 0.9%-13.8%) and “more conservative” for protein S deficiency (antepartum 0.9%, 95% CI 0.0%-3.7%; postpartum: 4.2%, 95% CI 0.7%-9.4%).

They also noted that absolute risk estimates for heterozygous factor V Leiden and heterozygous prothrombin G20210A mutation “were lower compared with ACCP guidelines.”

Croles and colleagues concluded that while “further research for more precise estimates is needed,” women with antithrombin or protein C or protein S deficiencies and family history of venous thromboembolism, and all women with homozygous factor V Leiden mutation should be considered for routine thrombosis prophylaxis. But both the risk estimates and chosen thresholds for treatment do not support routine use of this treatment for women with heterozygous factor V Leiden or heterozygous prothrombin G20210A mutations or compound heterozygous factor V Leiden and prothrombin G20210A mutation, they added.

Croles disclosed no conflicts of interest.

Other co-authors disclosed support from Ferring Pharmaceuticals, Pfizer, Daiichi Sankyo, Boehringer Ingelheim, Bayer Nederland, Pfizer Nederland, Baxter, Sanquin, Bristol-Myers Squibb, Uniqure, Shire, Novonordisk, CSL Behring, Baxalta (Shire) and Roche.

2017-10-27T17:00:00-0400

Tagged with:

About author

Related Articles